A detailed history of Kingsview Wealth Management, LLC transactions in Compugen LTD stock. As of the latest transaction made, Kingsview Wealth Management, LLC holds 83,179 shares of CGEN stock, worth $136,413. This represents 0.0% of its overall portfolio holdings.

Number of Shares
83,179
Previous 83,179 -0.0%
Holding current value
$136,413
Previous $214,000 35.05%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

SELL
$0.53 - $2.0 $430 - $1,624
-812 Reduced 0.97%
83,179 $164,000
Q3 2023

Nov 07, 2023

BUY
$0.88 - $1.31 $73,912 - $110,028
83,991 New
83,991 $78,000

Others Institutions Holding CGEN

About COMPUGEN LTD


  • Ticker CGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,600
  • Market Cap $142M
  • Description
  • Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...
More about CGEN
Track This Portfolio

Track Kingsview Wealth Management, LLC Portfolio

Follow Kingsview Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingsview Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kingsview Wealth Management, LLC with notifications on news.